These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 1229421)

  • 21. [Changes in blood coagulation physiology of wound blood].
    Trobisch H
    Beitr Infusionsther; 1993; 29():118-25. PubMed ID: 7690644
    [No Abstract]   [Full Text] [Related]  

  • 22. [Changes in the blood coagulation system in obliterating diseases of the arteries of the extremities].
    Krastin OA
    Sov Med; 1971 Apr; 34(4):65-9. PubMed ID: 5143757
    [No Abstract]   [Full Text] [Related]  

  • 23. [Blood coagulation, fibrinolysis and vascular wall injury].
    Nakamura K
    Rinsho Ketsueki; 1983 Sep; 24(9):1214-21. PubMed ID: 6229652
    [No Abstract]   [Full Text] [Related]  

  • 24. The anatomical distribution of plasma fibrinolytic activity in man during cardiac catheterisation.
    Gough SC; Smyllie J; Sheldon T; Rice PJ; Grant PJ
    Thromb Haemost; 1992 Oct; 68(4):442-7. PubMed ID: 1448778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical review of the evidence supporting a relationship between impaired fibrinolytic activity and venous thromboembolism.
    Prins MH; Hirsh J
    Arch Intern Med; 1991 Sep; 151(9):1721-31. PubMed ID: 1888237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinolysis and the risk of venous and arterial thrombosis.
    Meltzer ME; Doggen CJ; de Groot PG; Rosendaal FR; Lisman T
    Curr Opin Hematol; 2007 May; 14(3):242-8. PubMed ID: 17414214
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bloodless measurement of the venous pressure. A method for routine studies of venous circulation disorders].
    Kuiper JP; Brakkee AJ
    Hautarzt; 1971 Apr; 22(4):153-9. PubMed ID: 5553698
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of venous occlusion and local exercise on fibrinolytic activity and clotting time of blood.
    Malathi A; Parulkar VG
    Indian J Physiol Pharmacol; 1985; 29(3):175-7. PubMed ID: 3836195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical application of fibrinolysis laboratory tests: a review.
    Prisco D; Conti AA; Giurlani L; Falciani M
    Ann Ital Med Int; 1998; 13(2):81-7. PubMed ID: 9734140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Control and regulation of fibrinolysis in patients with arteriopathies by the use of an extractive mucopolysaccharide complex].
    Centonza D; Brina A; De Cristoforo A
    Minerva Med; 1969 Dec; 60(99 Suppl):5023-33. PubMed ID: 4188586
    [No Abstract]   [Full Text] [Related]  

  • 31. "Studies on the levels of fibrinolytic-activity with special reference to its range of activity on various substrates (including coagulation factors) in healthy controls". I.
    Bharadwaj TP; Sen NK
    J Assoc Physicians India; 1971 Jan; 19(1):43-8. PubMed ID: 5560025
    [No Abstract]   [Full Text] [Related]  

  • 32. [Changes induced by venous occlusion in coagulation and fibrinolysis in patients with old myocardial infarction].
    Suzuki T; Yamauchi K; Yamada Y; Furumichi T; Furui H; Saito H
    Kokyu To Junkan; 1991 Jan; 39(1):45-50. PubMed ID: 2024072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fibrinolysis in internal medicine].
    Breda R; Bizzi B
    Minerva Med; 1972 Dec; 63(88):4803-7. PubMed ID: 4641450
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrinolysis and kinin system activity of venous and arterial blood in patients suffering from arteriosclerosis obliterans.
    Lukjan H; Bielawiec M; Korfel B
    Bibl Anat; 1975; 13():297-8. PubMed ID: 1231761
    [No Abstract]   [Full Text] [Related]  

  • 35. [State of the blood coagulation system in patients with autonomic-vascular syndrome before and after treatment].
    Bondarenko LP
    Vrach Delo; 1973 Jul; 7(7):24-6. PubMed ID: 4756043
    [No Abstract]   [Full Text] [Related]  

  • 36. [Study on the influence of vasculo-tissular factors on coagulation and fibrinolysis. X. Release of anticoagulants and plasminogen activators after induced venous stasis and behavior of the coagulative-fibrinolytic system in subjects with recent myocardial infarct].
    Neri Serneri GG; Rossi Ferrini PL; Paoletti P; Silvestrini E; Masotti G
    Mal Cardiovasc; 1966; 7(2):237-56. PubMed ID: 5335302
    [No Abstract]   [Full Text] [Related]  

  • 37. [Blood coagulation and fibrinolysis in patients with pulmonary tuberculosis suffering from chronic alcoholism].
    Larionov VG; Potaĭchuk VI; Mel'nik VP
    Vrach Delo; 1989 Aug; (8):46-7. PubMed ID: 2588527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of preeclampsia and eclampsia on cord blood coagulation tests.
    Djelmis J; Buković D; Ivanisević M; Kovacević V; Pfeifer D
    Coll Antropol; 1998 Jun; 22(1):113-7. PubMed ID: 10097426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fibrinolytic activity of cerebrospinal fluid as an indicator of the risk of repeated ruptures of arterial aneurysms].
    Kholodov SA; Shelkovskiĭ VN; Platonova TK
    Zh Vopr Neirokhir Im N N Burdenko; 1985; (4):18-22. PubMed ID: 4050242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.